Over the past decade, early-stage drug innovation has shifted toward China, researchers find

Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research described by Georgetown University health policy experts.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup